PAINCHEK LTD — Capital/Financing Update 2019

Nov 25, 2019

==> picture [168 x 38] intentionally omitted <==

26 November 2019

PainChek Limited ( ASX: PCK ) ABN 21 146 035 127 Suite 401, 35 Lime Street, Sydney, NSW, 2000 Registered Office: Suite 5, 95 Hay Street Subiaco WA 6008 Phone +61 8 9388 8290 info@paincheck.com

Enliven (Presbyterian Support Southland) license PainChek®

monitoring technology across 5 aged care homes and 300

beds in New Zealand

PainChek Limited (ASX: PCK), a leading digital health company developing smart device applications for pain assessment and monitoring, and Enliven (Presbyterian Support Southland) (“Enliven”), a leading New Zealand Aged Care provider are pleased to announce the execution of a landmark PainChek® license agreement. Through this continued rapid advance of the PainChek® international expansion strategy, the PainChek® App will be accessible to Enliven’s nursing and care staff to assess their residents’ clinical pain levels. Enliven own and operate 5 aged care homes across New Zealand’s South Island comprising 300 aged care beds.

The license agreement follows a successful PainChek® trial at Enliven’s Peacehaven Village home. “The research shows us that pain often goes unrecognised and undertreated in people with communication difficulties, or those living with dementia. With this app, we can unobtrusively carry out a clinical pain assessment in just a few minutes and even in circumstances when a patient is resting. You know it’s a win-win situation when you’re embracing new technology which helps deliver timely and better client care, and it’s also providing your staff, as carers, with an easier and improved work environment” said Carol Riddle, Peacehaven Manager.

“This agreement is a first in New Zealand and the first where PainChek® is fully integrated with the Procura Clinical suite from the outset. This validates our strategy and the power of a fully integrated pain assessment solution improving clinical care, driving better efficiencies and giving back more clinical time for the clinical staff.” commented Philip Daffas, CEO of PainChek Ltd.

PainChek® is now live and fully integrated across the 5 Enliven aged care homes. The projected revenues expected from this contract is consistent with the standard PainChek® annual subscription license agreements[1] .

(1) The PainChek monthly Average Revenue per Licensed Bed (ARLB) across the RAC customers based on the agreements signed to date is in the range of $5 per month, and the Average Revenue per Active Resident (ARAR) is in the range of $10 per month based on actual resident usage. See ASX release dated 31 July 2018.

==> picture [594 x 82] intentionally omitted <==

==> picture [168 x 38] intentionally omitted <==

For further information contact: Ian Hobson Philip Daffas Company Secretary Managing Director Tel: +61 8 9388 8290 Tel: +61 406 537 235

- Ends -

==> picture [594 x 82] intentionally omitted <==

==> picture [168 x 38] intentionally omitted <==

About PainChek®

PainChek® Ltd is an Australian based company that develops pain assessment technologies.

PainChek® is a smart-phone based medical device using artificial intelligence to assess and score pain levels in real time and update medical records in the cloud. PainChek® records a short video of the person’s face and analyses the images that indicate pain and records them.

Next, the caregiver uses PainChek® to record their observations of other pain related behaviours that complete the assessment. Finally, PainChek® calculates an overall pain score and stores the result allowing the caregiver to monitor the effect of medication and treatment over time.

PainChek® is being rolled out globally in two phases: first, PainChek® for adults who are unable to effectively verbalise their pain such as people with dementia, and second, PainChek® for Children who have not yet learnt to speak.

The PainChek® Shared Care Program is a PainChek® licensing model which enables a professional carer to share their resident or patient data securely with other healthcare professionals or designated homebased family carers for ongoing pain assessments or clinical data review.

To find out more, visit www.painchek.com

==> picture [208 x 210] intentionally omitted <==

PainChek[®] artificial intelligence assesses facial micro-expressions that are indicative of the presence of pain.

==> picture [208 x 210] intentionally omitted <==

PainChek[®] domains of pain assessment that calculates pain severity score.

==> picture [594 x 82] intentionally omitted <==